![](/img/cover-not-exists.png)
Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents
A Kadiri, A Chraibi, F Marouan, M.R Ababou, N El Guermai, A Wadjinny, A Kerfati, M Douiri, J.D Bensouda, J Belkhadir, Y ArvanitisVolume:
41
Year:
1998
Language:
english
DOI:
10.1016/s0168-8227(98)00055-2
File:
PDF, 317 KB
english, 1998